title: Development Of A Model To Assess The Cost-Effectiveness Of Therapies For Patients With Type 2 Diabetes Mellitus (T2DM) Following A Reference Model Framework.
authors.affiliation: Amaris Consulting UK, London, UK.
authors.forename: R
authors.initials: R
authors.lastname: Aguiar-Ibáñez
authors.affiliation: Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Palencia
authors.affiliation: Boehringer Ingelheim UK, Bracknell, UK.
authors.forename: P
authors.initials: P
authors.lastname: Kandaswamy
authors.affiliation: Boehringer Ingelheim Canada Ltd, Burlingon, ON, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Flavin
authors.affiliation: Amaris, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Gauthier
authors.affiliation: University of Leicester, Leicester, UK.
authors.forename: M J
authors.initials: MJ
authors.lastname: Davies